Accium Biosciences
Latest round
- Series A
Last raised
- Jan 2006
Total raised
- $3M
Investors
- 1
About Accium Biosciences
Accium Biosciences specializes in innovative radiopharmaceutical solutions aimed at improving drug development and personalized medicine.Accium Biosciences operates as a biopharmaceutical company that develops radiopharmaceutical therapies. Founded in Seattle, US, it was established by Glenn Kawasaki who has a background in the biopharmaceutical industry.Accium Biosciences provides a suite of radiopharmaceutical products aimed at enhancing the drug development process for clients in diverse industries. Their offerings include specialized radioproducts designed for use in clinical trials, which facilitate targeted drug delivery and improve patient outcomes. The company caters to various customers, from small biotech firms to large pharmaceutical corporations, operating in regions including North America, Europe, and Asia.The company’s revenue model is primarily based on Business-to-Business (B2B) transactions, leveraging partnerships and contracts with clients. Accium’s primary offerings are structured under tiered pricing plans, allowing clients to select packages that fit their operational needs.Accium Biosciences plans to introduce new radiopharmaceutical products aimed at enhancing the precision of treatment options available in the market.
Who invested in Accium Biosciences
1 investor across 1 round
See all investors in Accium Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jan 6, 2006
Amount
$3M
Investors
Questions about Accium Biosciences
Who invested in Accium Biosciences?
Accium Biosciences has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Accium Biosciences raised?
Accium Biosciences has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Accium Biosciences last raise money?
Accium Biosciences's most recent round on record is a Series A, in Jan 2006.
What does Accium Biosciences do?
Accium Biosciences specializes in innovative radiopharmaceutical solutions aimed at improving drug development and personalized medicine.
Where is Accium Biosciences headquartered?
Accium Biosciences is headquartered in Seattle, US.
Which VCs invest in companies like Accium Biosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Accium Biosciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Accium Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.